EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2026 -61.58
June 30, 2026 -1.187
March 31, 2026 -1.288
December 31, 2025 -1.306
September 30, 2025 -1.808
June 30, 2025 -6.317
March 31, 2025 -0.2975
December 31, 2024 -18.45
September 30, 2024 -1.033
June 30, 2024 -1.009
March 31, 2024 -1.105
December 31, 2023 -1.87
September 30, 2023 -1.542
June 30, 2023 -1.940
March 31, 2023 -3.533
December 31, 2022 -16.23
September 30, 2022 -7.433
June 30, 2022 -6.480
March 31, 2022 -4.077
December 31, 2021 -4.056
September 30, 2021 -3.847
June 30, 2021 -4.098
March 31, 2021 -2.879
December 31, 2020 -33.89
September 30, 2020 -10.98
Date Value
June 30, 2020 -2.659
March 31, 2020 -3.170
December 31, 2019 -4.671
September 30, 2019 -3.116
June 30, 2019 -3.508
March 31, 2019 -2.717
December 31, 2018 -2.205
September 30, 2018 -3.087
June 30, 2018 -4.20
March 31, 2018 -4.20
September 30, 2017 -549.04
June 30, 2017 -245.00
March 31, 2017 -245.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.510
Corcept Therapeutics, Inc. 1.010
Veru, Inc. -0.3032
Johnson & Johnson 0.0858
Eli Lilly & Co. 7.221

EPS Diluted (Quarterly) Related Metrics